Community Scientists in protocol review were rated effective by 80% of surveyed researchers, with 60% adopting recommendations for translation, parking, and financial support.
Does integrating Community Scientists into the protocol review process improve the cultural relevance and inclusivity of investigator-initiated cancer trials?
Integrating community scientists into clinical trial protocol review is viewed by researchers as an effective strategy to enhance the cultural relevance and inclusivity of investigator-initiated trials.
Tasa de eventos absoluta: 0% vs 0%
Abstract Introduction: Investigator-Initiated Trials (IITs) advance scientific discovery, test interventions, and address unmet clinical needs; however, traditional research processes often overlook the perspectives of communities most affected by cancer disparities, leading to protocols that unintentionally reinforce barriers to participation among underrepresented groups. Community Scientists, comprising patients, caregivers, health professionals, and community leaders, offer lived expertise to ensure that study materials, eligibility criteria, and recruitment strategies reflect the realities of the populations affected by cancer. Methods: Cedars-Sinai Cancer Center Community Outreach Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 2479.
Balingit et al. (Fri,) reported a other. Community Scientists in protocol review were rated effective by 80% of surveyed researchers, with 60% adopting recommendations for translation, parking, and financial support.